Aarkstore - Evolution of Technologies for Therapeutic Antibodies-From mAbs to Biosimilars

Scope of report

The scope of the report is to highlight and gauge existing technologies in the production of therapeutic mAbs. The report also discusses key insights on interchangeability and substitution of therapeutic antibodies and biosimilars.
Further, there is also an assessment of the current drivers and restraints that affect the uptake of biosimilars.

The report answers key questions that are paramount for understanding the technologies involved in the production of therapeutic antibodies, such as:

• What are the various types of monoclonal therapeutic antibodies?
• Why is there a need for alternate forms of therapeutic antibodies?
• What is the likely future direction for research in the development and manufacture of monoclonal antibodies?
• What are the key features of a genetically modified mouse for antibody production?
• How do ethical concerns drive the direction of research of future monoclonal antibodies?
• What are the crucial features in establishing biosimilarity?
• Is interchangeability between innovator monoclonal antibodies and biosimilars ever achievable?
• What are the limitations in the technologies used to evaluate the extents of biosimilarity?
• Who are the potential players in biosimilar manufacture and what stage of product pipeline is their focus on?
• What are the current biosimilars under development as an alternative for major mAbs?
• What is the existing balance between drivers and restraints in the uptake of biosimilars?

Main benefits / Why should you buy this report?

The idea of using antibodies for therapy is about a century old. The successful production of antibodies has always been stalled by challenges like immunogenicity, scaling to industry level production, microheterogenity, regulatory approvals and pricing. This report will help stakeholders to understand prevailing technologies and their merits and limitations. It discusses:
• Technological deterrents encountered so far and the successful strategies to neutralize these
• The contemporary situation and forthcoming prospects of existing technologies
• The stages of the product pipeline that enterprises are centring on for success
• Ethical and regulatory considerations that set the path for the future

You can order full Report @

http://www.aarkstore.com/biotechnology/117430/evolution-of-technologies-for-therapeutic-antibodiesfrom-mabs-to-biosimilars

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
 Our News Section : http://www.aarkstore.com/news

Aarkstore - Healthcare Market Access: Morocco

The report provides in-depth information on:

o Country Landscape – The section details about the geographical details of Morocco. It also details the prevalent economic conditions of Morocco in terms of GDP per capita, GDP sources, demographic profile of the country, and political structure and environment.

o Healthcare infrastructure – The section provides data on the current health and hygiene status of the citizens based parameters such as: sanitation and safe drinking water access, HIV/AIDS prevalence, contraceptive usage, maternal and infant mortality, hospital bed and physician density etc. The sections also give detailed account of general healthcare structure of the country in terms of primary, secondary and tertiary care, and also a general note on the country’s health expenditure.

o Pharmaceutical Market Access: The sections gives detailed account of various types of health insurance currently operating in Morocco, their coverage in terms of health risks and benefits and also in terms of population coverage. The section gives detailed account of health insurance for public sector and private sector employees. The section also compares the efficiencies of various African medical regulatory agencies and their approval approach for a MNC pharmaceutical company. More specifically, the section deals with the regulatory agency and the new drug and reimbursement approval in Morocco.

Key questions answered in this report:

The report answers majority of key questions that are paramount for the success of a pharmaceutical company such as:
• Economic status of the country: GDP, GDP per capita, growth rate, major sources of GDP, income distribution
• Demographic structure of the country: age wise distribution of population, growth rate of population, educational level of population
• Healthcare infrastructure and status of the country: access to safe drinking and sanitary facilities reflecting the social hygiene, maternal and infant mortality rates reflecting the satus of healthcare scenario, expenditure eon healthcare, hospital bed and physician density reflecting the healthcare infrastructure of the state
• Healthcare system of the country: in terms of private and public healthcare infrastructure, primary, secondary and tertiary healthcare setups.
• Health insurance system in the country: Different forms of health insurance system and their governing bodies, the coverage of health insurance for public and private employees, penetration of health insurance etc.
• New drug approval process and reimbursement approval process

Key benefits / Why should you buy this report:

As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization.

This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to:

• Understand the macro and micro parameters that will play a pivotal role in making business decisions
• Identify, target and collaborate with the relevant stakeholders that hold key to effective product commercialization
• Conceptualize and formulate plausible market access strategies based on the insights generated
• Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country
• Capitalize on the opportunities presented by the country’s pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies
• Generate market specific insights that are actionable and commercially viable
• Leverage market access insights by incorporating physicians and payer priorities so as to develop effective sales and marketing strategies resulting in increased brand and company revenue
• Correctly ascertain the appropriate market access levers and barriers that will drive or hamper the brand performance
• Prioritize and assign optimal resources required for implementation of various market access activities   

You can order full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/117429/healthcare-market-access-morocco

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
 Our News Section : http://www.aarkstore.com/news

Aarkstore - Healthcare Market Access: Egypt

The report provides in-depth information on:

o Country Landscape – This section covers information on the prevailing economic environment in the country and the reform efforts being taken. The GDP growth has improved indicating trends in the economic indicators and improvement. The demographic profile of the country indicates that a majority of the population is young

o Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section. Moreover, healthcare expenditure and major healthcare providers are mentioned. The profiles of major hospitals and the number of healthcare personnel in the country are also covered.

o Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of size, growth, product mix and key players operating in the country. A special emphasis has been laid on the key drivers and barriers impacting the pharmaceutical market of the country. Furthermore, major diseases with high burden for the country have been covered.

o Market Access: This section dwells on the role and importance of various stakeholders in product commercialization process and gatekeepers holding the key to the access for pharmaceutical products. Various regulatory aspects crucial for approval and marketing of various categories of pharmaceutical products have been captured. In addition, analysis of pricing and reimbursement landscape along with the prescribing policies are covered.

Key questions answered in this report:

The report answers majority of key questions that are paramount for the success of a pharmaceutical company such as:

• How stable is the country’s political climate, major economic indices like GDP size and growth, rate of inflation, FDI, etc. impacting the level of business sentiments
• How lucrative is the pharmaceutical market of the country in terms of size, growth, product portfolio mix, key market segments and the level of competitive intensity
• Who are the relevant stakeholders that needs to be engaged effectively for successful product commercialization
• What are the key trends and policies that may impact the future market access landscape and how to effectively counter them
• Which are the cost-containment measures that have been adopted by the country’s government and may be introduced in the near future
• Which are the major disease segments that a pharmaceutical company can focus for product launch and growth based on the disease burden in the country
• What are the key policies that impacts the pricing and reimbursement decisions in both public and private sector
• Whether the country’s pharmaceutical market represents a compelling commercial case to invest and offers significant opportunities that can be successfully tapped resulting in significant revenue generation

Key benefits / Why should you buy this report:

As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization.

This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to:

• Understand the macro and micro parameters that will play a pivotal role in making business decisions
• Identify, target and collaborate with the relevant stakeholders that hold key to effective product commercialization
• Conceptualize and formulate plausible market access strategies based on the insights generated
• Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country
• Capitalize on the opportunities presented by the country’s pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies
• Generate market specific insights that are actionable and commercially viable
• Leverage market access insights by incorporating physicians and payer priorities so as to develop effective sales and marketing strategies resulting in increased brand and company revenue
• Correctly ascertain the appropriate market access levers and barriers that will drive or hamper the brand performance
• Prioritize and assign optimal resources required for implementation of various market access activities

You can order full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/117428/healthcare-market-access-egypt

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
 Our News Section : http://www.aarkstore.com/news

Aarkstore - Healthcare Market Access: Thailand

The report provides in-depth information on:

o Country Landscape – This section covers information on the prevailing economic environment in the country. The GDP per capita has improved indicating trends in the economic indicators and improvement. The demographic profile of the country indicates that a majority of the population is in the economically productive age group.

o Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section. Moreover, healthcare expenditure and major healthcare providers are mentioned. The profiles of major hospitals and the number of healthcare personnel in the country are also covered.

o Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of size, growth, product mix and key players operating in the country. A special emphasis has been laid on the key drivers and barriers impacting the pharmaceutical market of the country. Furthermore, major diseases with high burden for the country have been covered.

o Market Access: This section dwells on the role and importance of various stakeholders in product commercialization process and gatekeepers holding the key to the access for pharmaceutical products. Various regulatory aspects crucial for approval and marketing of various categories of pharmaceutical products have been captured. In addition, analysis of pricing and reimbursement landscape along with the prescribing policies are covered.

Key questions answered in this report:

The report answers majority of key questions that are paramount for the success of a pharmaceutical company such as:

• How stable is the country’s political climate, major economic indices like GDP size and growth, rate of inflation, FDI, etc. impacting the level of business sentiments
• How lucrative is the pharmaceutical market of the country in terms of size, growth, product portfolio mix, key market segments and the level of competitive intensity
• Who are the relevant stakeholders that needs to be engaged effectively for successful product commercialization
• What are the key trends and policies that may impact the future market access landscape and how to effectively counter them
• Which are the cost-containment measures that have been adopted by the country’s government and may be introduced in the near future
• Which are the major disease segments that a pharmaceutical company can focus for product launch and growth based on the disease burden in the country
• What are the key policies that impacts the pricing and reimbursement decisions in both public and private sector
• Whether the country’s pharmaceutical market represents a compelling commercial case to invest and offers significant opportunities that can be successfully tapped resulting in significant revenue generation

Key benefits / Why should you buy this report:

As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization.

This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to:

• Understand the macro and micro parameters that will play a pivotal role in making business decisions
• Identify, target and collaborate with the relevant stakeholders that hold key to effective product commercialization
• Conceptualize and formulate plausible market access strategies based on the insights generated
• Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country
• Capitalize on the opportunities presented by the country’s pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies
• Generate market specific insights that are actionable and commercially viable
• Leverage market access insights by incorporating physicians and payer priorities so as to develop effective sales and marketing strategies resulting in increased brand and company revenue
• Correctly ascertain the appropriate market access levers and barriers that will drive or hamper the brand performance
• Prioritize and assign optimal resources required for implementation of various market access activities

You can order full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/117427/healthcare-market-access-thailand

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
 Our News Section : http://www.aarkstore.com/news

Aarkstore - Healthcare Market Access: Vietnam

The report provides in-depth information on:

o Country Landscape – This section covers information on the prevailing economic environment in the country and dwells on both macro and micro economic indicators. The demographic profile of the country highlights the growing importance of middle class and increasing access to internet. It also captures the political landscape along with the opportunities and challenges presented by the country.

o Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section. Moreover, healthcare expenditure and share of public and private sectors are prominently discussed in the section. The profiles of major hospitals and the number of healthcare personnel in the country are also comprehensively covered.

o Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of size, growth, product mix and key players operating in the country. A special emphasis has been laid on the key drivers and barriers impacting the pharmaceutical market of the country. Furthermore, the profiles of major diseases with high burden for the country have been covered.

o Market Access: This section dwells on the role and importance of various stakeholders in product commercialization process and gatekeepers holding the key to the access for pharmaceutical products. Various regulatory aspects crucial for approval and marketing of various categories of pharmaceutical products have been captured comprehensively. In addition, detailed analysis of pricing and reimbursement landscape along with the prescribing policies and influence, price build-up and trends and various drug lists impacting reimbursement is covered.

Data-rich tables and figures have been used generously to augment the report and assist the reader in better understanding of the subject matter.

Key questions answered in this report:

The report answers majority of key questions that are paramount for the success of a pharmaceutical company such as:

• How stable is the country’s political climate, major economic indices like GDP size and growth, rate of inflation, FDI, etc. impacting the level of business sentiments
• How lucrative is the pharmaceutical market of the country in terms of size, growth, product portfolio mix, key market segments and the level of competitive intensity
• Who are the relevant stakeholders that needs to be engaged effectively for successful product commercialization
• What are the key factors that influence the physician prescribing habits and payer/hospital formulary decisions
• What are the key trends and policies that may impact the future market access landscape and how to effectively counter them
• Which are the cost-containment measures that have been adopted by the country’s government and may be introduced in the near future
• Which are the major disease segments that a pharmaceutical company can focus for product launch and growth based on the disease burden in the country
• What are the key policies that impacts the pricing and reimbursement decisions in both public and private sector
• Whether the country’s pharmaceutical market represents a compelling commercial case to invest and offers significant opportunities that can be successfully tapped resulting in significant revenue generation

Key benefits / Why should you buy this report:

As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization.

This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to:

• Understand the macro and micro parameters that will play a pivotal role in making business decisions
• Identify, segment, target and collaborate with the relevant stakeholders that hold key to effective product commercialization
• Conceptualize and formulate plausible market access strategies based on the insights generated
• Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country
• Capitalize on the opportunities presented by the country’s pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies
• Generate market specific insights that are actionable and commercially viable
• Leverage market access insights by incorporating physicians and payer priorities so as to develop effective sales and marketing strategies resulting in increased brand and company revenue
• Correctly ascertain the appropriate market access levers and barriers that will drive or hamper the brand performance
• Prioritize and assign optimal resources required for implementation of various market access activities

You can order full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/117424/healthcare-market-access-vietnam

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
 Our News Section : http://www.aarkstore.com/news

Aarkstore - Healthcare Market Access: Poland

The report provides in-depth information on:

o Country Landscape – This section covers information on the prevailing economic environment in the country and the reform efforts being taken. The GDP growth has improved indicating trends in the economic indicators and improvement. The demographic profile of the country indicates a negative population growth rate

o Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section. Moreover, healthcare expenditure and major healthcare providers are mentioned. The profiles of major hospitals and the number of healthcare personnel in the country are also covered.

o Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of size, growth, product mix and key players operating in the country. A special emphasis has been laid on the key drivers and barriers impacting the pharmaceutical market of the country. Furthermore, major diseases with high burden for the country have been covered.

o Market Access: This section dwells on the role and importance of various stakeholders in product commercialization process and gatekeepers holding the key to the access for pharmaceutical products. Various regulatory aspects crucial for approval and marketing of various categories of pharmaceutical products have been captured. In addition, analysis of pricing and reimbursement landscape along with the prescribing policies are covered.

Key questions answered in this report:

The report answers majority of key questions that are paramount for the success of a pharmaceutical company such as:

• How stable is the country’s political climate, major economic indices like GDP size and growth, rate of inflation, FDI, etc. impacting the level of business sentiments
• How lucrative is the pharmaceutical market of the country in terms of size, growth, product portfolio mix, key market segments and the level of competitive intensity
• Who are the relevant stakeholders that needs to be engaged effectively for successful product commercialization
• What are the key trends and policies that may impact the future market access landscape and how to effectively counter them
• Which are the cost-containment measures that have been adopted by the country’s government and may be introduced in the near future
• Which are the major disease segments that a pharmaceutical company can focus for product launch and growth based on the disease burden in the country
• What are the key policies that impacts the pricing and reimbursement decisions in both public and private sector
• Whether the country’s pharmaceutical market represents a compelling commercial case to invest and offers significant opportunities that can be successfully tapped resulting in significant revenue generation

Key benefits / Why should you buy this report:

As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization.

This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to:

• Understand the macro and micro parameters that will play a pivotal role in making business decisions
• Identify, target and collaborate with the relevant stakeholders that hold key to effective product commercialization
• Conceptualize and formulate plausible market access strategies based on the insights generated
• Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country
• Capitalize on the opportunities presented by the country’s pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies
• Generate market specific insights that are actionable and commercially viable
• Leverage market access insights by incorporating physicians and payer priorities so as to develop effective sales and marketing strategies resulting in increased brand and company revenue
• Correctly ascertain the appropriate market access levers and barriers that will drive or hamper the brand performance
• Prioritize and assign optimal resources required for implementation of various market access activities

You can order full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/117425/healthcare-market-access-poland

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
 Our News Section : http://www.aarkstore.com/news

Aarkstore - Healthcare Market Access: Indonesia

The report provides in-depth information on:

o Country Landscape This section covers information on the prevailing economic environment in the country and dwells on both macro and micro economic indicators. The demographic profile of the country highlights the growing importance of middle class and increasing access to internet. It also captures the political landscape along with the opportunities and challenges presented by the country.

o Healthcare infrastructure Insightful review of the countrys healthcare system and health status with key health indicators are presented in this section. Moreover, healthcare expenditure and share of public and private sectors are prominently discussed in the section. The profiles of major hospitals and the number of healthcare personnel in the country are also comprehensively covered

o Overview of Pharmaceutical Market This section depicts the pharmaceutical market in terms of size, growth, product mix and key players operating in the country. A special emphasis has been laid on the key drivers and barriers impacting the pharmaceutical market of the country. Furthermore, the profiles of major diseases with high burden for the country have been covered

o Market Access: This section dwells on the role and importance of various stakeholders in product commercialization process and gatekeepers holding the key to the access for pharmaceutical products. Various regulatory aspects crucial for approval and marketing of various categories of pharmaceutical products have been captured comprehensively. In addition, detailed analysis of pricing and reimbursement landscape along with the prescribing policies and influence, price build-up and trends and various drug lists impacting reimbursement is covere

Data-rich tables and figures have been used generously to augment the report and assist the reader in better understanding of the subject matter

Key questions answered in this report:

The report answers majority of key questions that are paramount for the success of a pharmaceutical company such as:

How stable is the countrys political climate, major economic indices like GDP size and growth, rate of inflation, FDI, etc. impacting the level of business sentiments

How lucrative is the pharmaceutical market of the country in terms of size, growth, product portfolio mix, key market segments and the level of competitive intensity

Who are the relevant stakeholders that needs to be engaged effectively for successful product commercialization

What are the key factors that influence the physician prescribing habits and payer/hospital formulary decisions

What are the key trends and policies that may impact the future market access landscape and how to effectively counter them

Which are the cost-containment measures that have been adopted by the countrys government and may be introduced in the near future

Which are the major disease segments that a pharmaceutical company can focus for product launch and growth based on the disease burden in the country

What are the key policies that impacts the pricing and reimbursement decisions in both public and private sector

Whether the countrys pharmaceutical market represents a compelling commercial case to invest and offers significant opportunities that can be successfully tapped resulting in significant revenue generation

Key benefits / Why should you buy this report:

As every countrys market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization.

This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to

Understand the macro and micro parameters that will play a pivotal role in making business decisions

Identify, segment, target and collaborate with the relevant stakeholders that hold key to effective product commercialization

Conceptualize and formulate plausible market access strategies based on the insights generated

Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country

Capitalize on the opportunities presented by the countrys pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies

Generate market specific insights that are actionable and commercially viable

Leverage market access insights by incorporating physicians and payer priorities so as to develop effective sales and marketing strategies resulting in increased brand and company revenue

Correctly ascertain the appropriate market access levers and barriers that will drive or hamper the brand performance

Prioritize and assign optimal resources required for implementation of various market access activities

You can order full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/117423/healthcare-market-access-indonesia

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
 Our News Section : http://www.aarkstore.com/news